Introduction
Chordomas are rare locally aggressive neoplasms of notochordal origin, constituting 2 to 4% of primary bone tumors.
1
In contrast to ecchordosis physaliphora (EP), which are usually small incidentally discovered rests of tissue within the clivus or retroclival space, cranial base chordomas mostly arise extradurally and produce symptoms secondary to growth and bony destruction. Rare cases of extraosseous intradural chordoma have been reported and generally considered to have a more favorable prognosis relative to typical chordomas. [2] [3] [4] We report a case of a giant intradural chordoma lacking bony involvement. We furthermore performed a systemic review of
Materials and Methods
The current study is a systematic review of the literature applying the Preferred Reporting Items for Systematic Reviews guidelines. 5 All studies included were case reports or small primarily retrospective case series.
Search Strategy
A systematic electronic article search was conducted through Medline between 1974 and 2013, using the Medical Subject Heading terms chordoma, ecchordosis physaliphora, notochord, bone neoplasms, and skull base neoplasms. Titles and abstracts were then reviewed to identify cases of intradural chordomas or ecchordosis physaliphora. A manual search was also conducted from the reference lists of selected articles to identify additional studies. Of these articles, a full-text review was performed by two coauthors independently (F.A. and S.D.), applying inclusion and exclusion criteria to obtain a final group of included studies. Studies were included if (1) they reported patients with histologically confirmed intradural chordomas or ecchordosis physaliphora; (2) patients were symptomatic and/or had large (! 3 cm maximal diameter) or growing tumors; and (3) tumors were found to have bony stalk without evidence of bony destruction. Articles were excluded if (1) patients were asymptomatic and/or had small (< 1 cm maximal diameter) tumors; (2) if the article was an autopsy, nonsurgical, or pure radiologic series; and (3) if the patient was treated in the era before computed tomography (CT) or magnetic resonance imaging (MRI).
Data Collection
After a final list of articles was assembled, individual patient data were extracted and compiled on to a master database. Patient age, sex, tumor size, location, pathologic diagnosis, presenting symptoms, extent of surgical resection, adjuvant therapy, follow-up duration, recurrence, and mortality were all recorded.
Statistical Analyses
From the compiled patient database, 5-year overall OS and RFS were calculated using the Kaplan-Meier method. Risk factors for progression or mortality were analyzed using binomial logistic regression. An assessment of risk of bias was not possible for this study. A p value <0.05 was considered to be statistically significant. Statistics were performed using IBM SPSS v.21.0 (IBM, Inc, Armonk, New York, United States).
Results
An initial systematic Medline search yielded 416 publications. After screening based on title and abstract review and applying the previously described inclusion and exclusion criteria, there were 38 publications including 47 patients. The details of each study are tabulated in Appendix A, and subject demographics from the literature cases and ours (48 patients total) are summarized in ►Table Survival data were available for 32 of 48 patients. Based on the Kaplan-Meier survival analysis of the compiled available individual patient data, 5-year RFS was 74% AE 11%, and mean RFS was 112.0 months (95% confidence interval [CI]: 86.6-137.5 months) (►Fig. 1A). The 5-year OS was 77% AE 11%; excluding 30-day surgical mortality, 5-year OS was 87% AE 7%. Mean OS was 115.9 months (95% CI, 90.7-141.2 months) (►Fig. 1B). The 5-year OS for patients undergoing complete resection was 92% AE 8%, compared with 63% AE 18% for those with subtotal resection (p ¼ 0.00004). The 5-year RFS for patients undergoing complete resection was 83% AE 15, compared with 64% AE 15% for those with subtotal resection (p ¼ 0.00290). Patients who developed recurrence had a larger tumor diameter (4.3 AE 0.5 cm versus 3.2 AE 1.2 cm; p ¼ 0.0390) and a more elevated Ki-67 index (6.83 AE 1.21% versus 1.03 AE 1.84%; p < 0.001) compared with those who did not (►Tables 2 and 3). Similarly, patients who died had a larger tumor diameter (4.8 AE 0.8 cm versus 3.2 AE 1.2 cm; p ¼ 0.039) and a more elevated Ki-67 index (6.83 AE 1.21% versus 1.03 AE 1.84%; p < 0.001) than those who survived. No other recurrence or survival-related risk factors analyzed were found to be statistically significant.
vectors. He also complained of decreased hearing and facial sensation on the left side. On examination, he had nearcomplete ophthalmoplegia in the left eye, as well as left ptosis and a fixed, dilated pupil. There was 20% subjective sensation in the left V1-3 dermatomes. His gait was ataxic, and he had psychomotor slowing as well as mild word-finding difficulty. He had diffuse hyperreflexia, and positive Hoffman and Babinski reflexes. There was bilateral upper and lower extremity dysmetria.
His magnetic resonance imaging (MRI) demonstrated a giant left petroclival intradural lesion extended from the jugular foramen caudally and superior to the tentorium to the parasellar space and cavernous sinus (►Fig. 2). A head computed tomography (CT) demonstrated a lack of any bony destruction, remodeling, or tumoral involvement. There was severe effacement of the brainstem and partial encasement of the basilar and ipsilateral vertebral arteries. The lesion appeared lobulated, hyperintense on T2, hypointense on T1, and there was only mild heterogeneous enhancement. The preoperative differential diagnosis included atypical meningioma, schwannoma, neuroepithelial cyst, and chordoma. A preoperative CT scan did not demonstrate any bony involvement of the tumor.
Operation
The patient underwent a left-sided posterior transpetrosal approach. Intraoperative monitoring of long tract motor-and sensory-evoked potentials, as well as brainstem auditory evoked responses and cortically evoked facial nerve motorevoked potentials was performed. The presigmoid dura was opened from above the jugular bulb across the superior petrosal sinus and to the temporal lobe. The vein of Labbé was seen coursing posteriorly to drain into the transverse sinus. The tentorium was divided posterior to the course of the trochlear nerve. An expansile mass was seen medial to the trochlear, trigeminal and VII-VIII nerves. It was debulked and mobilized without difficulty. Superiorly, the tumor was resected up to the cavernous sinus; however, the visualization offered by the approach was inadequate and a small remnant was believed to have been left behind. Medially, the tumor dissected very well off the brainstem and basilar artery. The tumor was followed into Meckel cave, which was partially unroofed and packed with Surgicel and Tisseel following tumor removal. The remainder of the tumor was removed, and intraoperative monitoring remained pristine throughout the case.
Pathology
All the histologic sections examined showed the presence of a tumoral proliferation composed of cells with vacuolated cytoplasm and areas resembling cartilage (►Fig. 3). In some areas, the cells formed anastomotic cords floating in a chondroid type of matrix. Cytokeratin immunohistochemistry was strongly positive, and there was focal but definite positivity for both S-100 and brachyury. The Ki-67 index was very low (< 0.5%), with only a few positive nuclei. Final diagnosis was consistent with chordoma.
Postoperative Course
Postoperative MRI (►Fig. 2) demonstrated complete resection of the posterior fossa tumor with an expected small remnant within the cavernous sinus. His postoperative course was complicated by a single partial complex seizure on postoperative day 1, for which antiepileptic medication was not started, and there were no further episodes. He also developed a pseudomeningocele that resolved spontaneously without specific intervention. His ataxia, weakness, psychomotor slowing, ptosis, and diplopia all resolved postoperatively, although clinically he continues to have a trochlear nerve palsy. At 3 months postoperatively, the patient received fractionated stereotactic radiotherapy (fSRT) with an intensity-modulated radiotherapy RAPID Arc system (Varian Medical Systems, Palo Alto, California, United States) using MRI fusion. A total dose of 52 Gy was delivered in 28 fractions. His last follow-up MRI at 12 months from surgery demonstrated no recurrence of the tumor.
Discussion
Luschka first described his finding of pathologic ectopic notochordal tissue at the posterior clivus in 1856. 9 In 1857, Virchow gave the first microscopic description and termed the lesion ecchondrosis physaliphora, believing it to be a process affecting the cartilage of the spheno-occipital enhancement in EP. 20 The presence of a bony stalk was reported in several cases; however, we did not find it to be a distinguishing feature of EP versus chordoma, nor did it appear to affect prognosis. Based on prior case reports and small series, intradural chordomas have generally been considered to have a more favorable prognosis and a different biologic behavior relative to typical cranial base chordomas. 8 The data from our systematic review suggest that both 5-year RFS and OS appear to be comparable with typical chordomas, particularly following a complete surgical resection. In a recent meta-analysis of cranial base chordomas, 21 5-year RFS was 87% in patients with complete resection compared with 50% in patients with incomplete resection, and 5-year OS was 95% with complete resection versus 71% without. This is similar to our study, in which 5-year RFS for patients undergoing complete resection was 83% AE 15, compared with 64% AE 15% for those with subtotal resection, and in which 5-year OS was 92% AE 8% with complete resection, compared with 63% AE 18% with incomplete resection (p < 0.001). Thus although a gross total resection may be more feasible for true intradural chordomas, their biologic behavior may nevertheless be similar to classic skull base chordomas and is reflected by similar survival of both subtypes after complete and incomplete resections. The cellular and molecular mechanisms by which chordomas effectuate bony invasion and overall aggressiveness remain poorly understood, and in light of the relative rarity of intradural chordomas and EP, differentiating features are as yet lacking. Proteases may be implicated in bony destruction in chordomas. Matrix metalloproteinases 22 and cathepsin K 22, 23 have been investigated as potential mediators; their increased expression appear related to worse prognosis. Adhesion proteins may also mediate tumor invasiveness in chordomas. Upregulation of N-cadherin and downregulation of E-cadherin may be correlated with worse clinical behavior of some chordomas. 24 Upregulation of specific proto-oncogenes have also been evaluated, including c-MET and hepatocyte growth factor expression. 25 Fascin overexpression was also correlated with increased chordoma invasiveness and dural penetration, implicating increased cell motility as a potential mechanism. 26 Increased telomerase activity also appears to correlate with chordoma recurrence and possible aggressiveness. 27 The cellular proliferative potential, as measured by the Ki-67 staining index, has been reported to distinguish EP from chordoma. 14, 15 Reported cases of EP typically have a Ki-67 index < 1%, whereas in chordoma it is > 2%. Accordingly, all the cases included in our systematic review demonstrated a Ki-67 index < 2% in EP. Our study is subject to several important limitations. All included studies are of a retrospective nature composed primarily of case reports and a few small case series, and they subject our meta-analysis to potential publication bias. Heterogeneity in the compiled cohort was observed due to local differences in the use of adjuvant radiation therapy, and often unclear justification for the pathologic distinction between EP and true chordoma. The histologic distinguishing features between chordoma and EP are unclear; there is heterogeneity in the pathologic distinction of intradural cases included in our literature synthesis. Finally, the overall small population limits statistical power.
Conclusion
Intradural cranial base chordomas are extremely rare. There is lack of uniform agreement regarding the distinguishing features of chordoma and ecchordosis physaliphora, particularly for large symptomatic tumors. Based on our metaanalysis, the clinical behavior of intradural chordomas may be closer to typical cranial base chordomas than was previously recognized. This finding may influence clinical management, particularly the use of adjuvant radiation therapy as in our case illustration. 
